Brachytherapy
Volume 5, Issue 2 , Page 79, April 2006

Pretreatment PSA velocity is associated with freedom from biochemical recurrence of prostate cancer following low-dose-rate prostate brachytherapy alone

  • Peter J. Rossi, M.D.

      Affiliations

    • Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC
    • ,
  • Micheal A. Papagikos, M.D.

      Affiliations

    • Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC
    • ,
  • Peter E. Clark, M.D.

      Affiliations

    • Urology, Wake Forest University School of Medicine, Winston Salem, NC
    • ,
  • W. Robert Lee, M.D., M.A.

      Affiliations

    • Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC

OR-4Presentation Time: 10:30 AM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(06)00055-9

doi:10.1016/j.brachy.2006.03.012

Brachytherapy
Volume 5, Issue 2 , Page 79, April 2006

Article Tools